The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Novel Methods To Study Structural-functional Connectivity In Epilepsy And Schizophrenia
Funder
National Health and Medical Research Council
Funding Amount
$697,605.00
Summary
Magnetic Resonance Imaging (MRI) is a non-invasive method that has revolutionised our understanding of clinical neuroscience. MRI provides not only high-contrast anatomical images, but also information on brain physiology and function. My primary goal is to develop and optimise novel MRI methods for a more accurate measure of brain structure and function. My research program will focus on the application of these methods to the investigation of epilepsy and schizophrenia.
Peptides (mini proteins) have outstanding potential as new drugs for cancer, pain and many other diseases, but their potential has not been realised so far because peptides tend to be unstable in the body. I have discovered a new class of peptides that are ultra-stable and have very favourable pharmaceutical properties. I will use these peptides to develop a new generation of drugs that are more potent and with fewer side effects than traditional drugs.
Detailed images of protein molecules underpin our understanding of biological function and our attempts to find new medicines to counter biological malfunction. Proteins belonging to the so-called Bcl-2 family determine whether a cell lives or dies and, because failure to die on cue is a hallmark of many cancers, high resolution images of these molecules will reveal new targets for cancer therapies.
Development Of Ultrahigh Resolution Brain Imaging For Investigating Neurological And Neurodegenerative Diseases
Funder
National Health and Medical Research Council
Funding Amount
$880,454.00
Summary
Understanding the structural and functional organisation of the human brain is the focus of enormous research effort. Neuroimaging is an extraordinarily important basic and clinical neuroscience discipline, and is unique in being able to provide direct in vivo measurements of the human brain, and crucially in individuals with brain and mind diseases. This research project will develop and utilise ultra-high resolution brain scanning to understand the mechanisms of neurodegenerative diseases.
Maps, Models And Modifiers Of Brain Changes In Psychosis
Funder
National Health and Medical Research Council
Funding Amount
$715,210.00
Summary
Psychosis fundamentally alters one’s relationship with reality. Brain scans can map which parts of the brain are affected by psychosis, but they cannot identify the cellular processes that cause these changes. My fellowship aims to address this gap by integrating brain imaging with genetics and mathematical modelling to identify the brain circuits and molecules that impact risk for psychosis, and to develop targeted therapies to modify these dysfunctional circuits.
Venoms To Drugs: Translating Venom Peptides Into Therapeutics
Funder
National Health and Medical Research Council
Funding Amount
$751,854.00
Summary
Chronic pain is a major global health problem that currently affects over three million Australians. There are few drugs available for treating chronic pain and many have significant side-effects. Several ion channels are critical for conducting pain signals to the brain. Blocking these channels can provide pain relief and, in some cases, protection from brain injury following stroke. We are producing potent and selective blockers of these ion channels for the treatment of chronic pain and strok ....Chronic pain is a major global health problem that currently affects over three million Australians. There are few drugs available for treating chronic pain and many have significant side-effects. Several ion channels are critical for conducting pain signals to the brain. Blocking these channels can provide pain relief and, in some cases, protection from brain injury following stroke. We are producing potent and selective blockers of these ion channels for the treatment of chronic pain and stroke.Read moreRead less
Prof Alan Connelly is an internationally recognised neuroimaging researcher specialising in MRI. His major areas of research are in the development of new methods to acquire and process MR images of both structural and functional aspects of the brain, and the application of these novel methods to clinical neuroscience problems. His work has had a major impact in the field of epilepsy, where techniques that he pioneered have been widely adopted in specialist epilepsy centres worldwide.
I am a neurophysiologist who examines the neural control of movement and the interaction of sensation and movement in human subjects. I study cortical and motoneuronal events during exercise and muscle fatigue, how cortical connections to the motoneurones change with practice of motor tasks, and whether they can be changed artificially. I also study proprioception i.e. the sensations related to relative position and movement of parts of the body and the production of muscle force.